article thumbnail

Role of AI In The Pharmaceutical Industry

Electronic Health Reporter

Artificial intelligence (AI) has the potential to generate $100 billion across the healthcare and pharmaceutical industry, according to Mckinsey. The article Role of AI In The Pharmaceutical Industry appeared first on electronichealthreporter.com.

article thumbnail

Industry Voices—How the pharmaceutical industry can turn the tide on mental health

Fierce Healthcare

Industry Voices—How the pharmaceutical industry can turn the tide on mental health. pminemyer. Fri, 05/13/2022 - 10:15

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Impact of Agile In The Pharmaceutical Industry

Electronic Health Reporter

As many know, the pharmaceutical industry is heavily regulated and specialized, with slow drug-development timelines, strict processes and quality requirements, and rigid silos. This article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited.

article thumbnail

The Gains and Pains of Using AI in the Pharmaceutical Industry

HIT Consultant

The proportion of pharmaceutical companies hiring for AI-related positions kept relatively steady in May 2022 compared with the equivalent month last year, according to a Pharmaceutical Technology study, with 39.3% Michael Galarnyk, AI Evangelist at cnvrg.io.

article thumbnail

Workforce training platform Transform launches to the pharmaceuticals industry

Mobi Health News

The platform provides solutions in energy health and safety training and now brings its training expertise to the pharmaceuticals sector

article thumbnail

CEO of Sanford-Burnham Resigns for Job in the Pharmaceutical Industry

The Health Law Firm

By George F. Indest, J.D., M.P.A., Board Certified by The Florida Bar in Health Law. Sanford-Burnham Medical Research Institute announced on January 14, 2013, that John C. Reed, M.D., has resigned as Chief Executive Officer (CEO). According to a press release from Sanford-Burnham, Dr. Reed accepted the position of Head of Roche Pharma Research and Early Development and member of the Corporate Executive Committee. Kristiina Vuori, M.D., president of Sanford-Burnham, will lead in the interim.

article thumbnail

Modern Technology: A Transformation of Drug Research

Electronic Health Reporter

Technology has revolutionized almost every aspect of life and the pharmaceutical industry doesn’t stay untouched. This article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited.

article thumbnail

Roundup: Sun Pharma reports IT breach and more briefs

Healthcare It News

Sun Pharma probes cyber breach Indian pharma giant Sun Pharmaceutical Industries has reported an "information security incident," according to PTI.

article thumbnail

European researchers, pharma players team up on gait detecting sensor

Mobi Health News

The European Federation of Pharmaceutical Industries and Associations and researchers across Europe teamed up on a €50 million project to develop a wearable sensor of clinical trials.

article thumbnail

The impact of COVID-19 on virtual trials

Mobi Health News

The need to accelerate virtual trials is just one takeout that Henry Levy, GM at Veeva Vault CDMS, talks about in an exclusive interview with MobiHealthNews, in which the impact of COVID-19 on the pharmaceutical industry is addressed

article thumbnail

Security, control of data seen as key barriers to cloud adoption by pharma

Mobi Health News

There's continued resistance from many pharmaceutical industry executives, who think it's never possible to safely store sensitive data in the cloud.

article thumbnail

Podcast: Impact of COVID-19 on Pharmacist Scope of Practice: Before and After the PREP Act – Diagnosing Health Care

Health Law Advisor

The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces.

article thumbnail

New Pharmaceuticals For 2020 and Beyond

Electronic Health Reporter

From rheumatoid arthritis to HIV, the pharmaceutical industry is well on its way to making this a banner year for new drug implementation. The article New Pharmaceuticals For 2020 and Beyond appeared first on electronichealthreporter.com. This article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited. Here are just a few exciting breakthroughs for big pharma in 2020. […].

article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

The selections feature topics ranging from how Wikipedia pages communicate drug efficacy information, to addressing pharmaceutical industry payments to physicians, to the frequency with which the Food and Drug Administration removes hazardous dietary supplements from the market.

article thumbnail

2023’s Biggest Pharma Cybersecurity Threats to Watch

HIT Consultant

Ransomware The threat of ransomware is nothing new, but cybercriminal tactics surrounding ransomware continue to evolve, making the pharma industry susceptible to these kinds of attacks now more than ever.

article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: Avista Acquires Taconic Biosciences From H.I.G. 

McGuire Wood

Founded in 2005, the firm focuses on the following healthcare subsectors: pharmaceuticals, medical devices, outsourced pharmaceutical services, distribution and consumer-driven healthcare. Avista Capital Partners has announced its acquisition of Taconic Biosciences from H.I.G.

article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: NovaQuest Invests in Bend Bioscience

McGuire Wood

Founded in 2021, the company specializes in particle engineering, drug delivery, drug development and manufacturing to the pharmaceutical industry. NovaQuest Private Equity (NQPE) has invested in Bend Bioscience, according to a news release. Bend Bioscience , based in Bend, Ore.,

article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: Amulet Capital Sells OPEN Health

McGuire Wood

offices, is a global provider of scientific communications and market access services to the pharmaceutical industry. Amulet Capital Partners has sold OPEN Health to Astorg, according to a news release. OPEN Health , established in 2011 and with several U.S.

article thumbnail

M&A: AmerisourceBergen Acquires Fintech Solution FirstView Financial

HIT Consultant

Founded in 2006, FirstView supports organizations across the pharmaceutical industry—from pharmaceutical manufacturers to hub providers and specialty pharmacies—by delivering seamless payment solutions that help partners manage and execute effective patient support programs.

article thumbnail

How pharmaceutical marketing affects decisions about patient care

Kaiser Permanente

As we search for ways to improve the value of prescription drugs and make them more affordable, pharmaceutical marketing poses a real challenge. In 2016, the 12 largest pharmaceutical companies spent more than $120 billion on marketing , compared to $75 billion on research and development.

article thumbnail

The Ultimate Guide to ISO 9001

Dot Compliance

The following is a list of some of the most prevalent rules and regulations that apply to the Pharmaceutical Quality Management System (QMS). Pharmaceuticals, for instance, must adhere to 21 CFR Part 211 in order to be supplied in the United States. Benefits of ISO 9001 Pharmaceutical.

article thumbnail

How Pharma Startups Can Remain Competitive in Today’s Market

HIT Consultant

Startups face both of these challenges when trying to break into existing industries dominated by well-established players. Differences in the size, speed, processes, and culture of a company make it challenging for all startups to compete, regardless of the industry.

article thumbnail

Depression doesn't look alike for everyone – so why should the treatments for it?

Healthcare IT News - Telehealth

"It has very much been a one-size-fits-all [approach] in the pharma industry." " Eriksson, a psychiatrist by training, has been working in the pharmaceutical industry for more than 20 years.

article thumbnail

Unlocking the Future of Health—and Care—with AI

Healthcare IT Today

Now, AI is effective across the healthcare and pharmaceutical industries. The Best Cure is Preventative This type of telehealth is revolutionizing what our care industry could look like, with faster triages and attentive post-operative check-ins in place.

article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

These pledges can take a variety of forms and have been made for decades in industries ranging from automotive (e.g., As noted above, patent pledges underlie industries ranging from telecommunications and computing to transportation and agriculture. By Jorge L. Contreras.

article thumbnail

Healthcare Industry Warned About Risk Posed by APT41 Threat Group

HIPAA Journal

The group gains access to networks and gathers intelligence that can be used in future attacks and steals industry-specific information. The group is considered to be a significant threat to the healthcare and pharmaceutical industries in the United States.

HIPAA 71
article thumbnail

Exploring The Value of Metaverse Use Cases in Life Sciences

HIT Consultant

While the pharmaceutical industry and life sciences are often criticized for slow technological adoption, the metaverse presents an enormous opportunity for early adoption built on a clear understanding of value.

article thumbnail

Beyond DocuSign: How to Upgrade Specialty Drug Patients to a First-Class Experience

HIT Consultant

Considering the pharmaceutical industry has spent billions of dollars and many years attempting to craft a concierge service for specialty patients, the typical patient journey is an unacceptable mess. Yishai Knobel, CEO/Co-Founder, HelpAround.

article thumbnail

QMS 101: Pharmaceutical Quality Management System

Dot Compliance

The Pharmaceutical Quality Management System (QMS) is a collection of activities and processes that improve the quality of the pharmaceutical product. Pharmaceutical QMS Regulatory Requirements & QMS Pharmaceutical Guidelines. Dot Compliance Pharmaceutical QMS.

article thumbnail

Why Researchers Should Explore New Apps of Machine Learning

HIT Consultant

Michael Munsell, Director of Research at Panalgo As the amount of real-world data (RWD) in the pharmaceutical industry continues to grow, so does the usage of machine learning (ML) to analyze that data and gain insights.

article thumbnail

Pharma – 2023 Health IT Predictions

Healthcare IT Today

Jesse Cugliotta, Global Industry GTM Lead, Healthcare & Life Sciences at Snowflake. One of the core issues is that the industry has become single threaded in its sourcing strategy. This could be a breakthrough for the pharmaceutical industry.

article thumbnail

Media Mix Transformation for Pharma Marketers: The Power of CTV & Digital Video

HIT Consultant

Lauren Ohlsson, Lead of Industry Solutions, Pharmaceutical and Healthcare, at VDX.tv. From a regulatory perspective, The Food and Drug Administration (FDA), in partnership with pharmaceutical companies, has stringent regulations for advertising to consumers and HCPs, alike.

article thumbnail

Buried Under Dirt or Under Debt: Can Patients Survive the Struggle of Getting Care?

HIT Consultant

Although non-specialty drugs are more commonly prescribed, high-cost specialty drugs represent a majority of pharmaceutical budgets. He brings to the company more than a decade of experience in the medical device industry. Srulik Dvorsky, TailorMed CEO and Founder.

article thumbnail

New Company, Velsera, Represents Summa Equity’s Vision to Improve Global Health Outcomes

Healthcare IT Today

Velsera’s initial formation comes with the acquisition of three global, industry-leading companies in the healthcare and life science industries: Pierian, Seven Bridges, and UgenTec. He has 30+ years of business experience, with 20 years in the healthcare and pharmaceutical industries.

article thumbnail

Specialty Pharma’s Next Big Opportunity: It’s Time for Patient Access to Adopt an Open Protocol

HIT Consultant

A similar inflection point now faces the specialty pharmaceutical industry. Not unlike the financial industry, these institutions still exchange patient information via fax machines. The industry preference for paper did not disappear overnight.